About PharmScript
PharmScript is a company based in Somerset (United States) founded in 2009 by Saul Greenberger. The company has 376 employees as of December 31, 2022. PharmScript has completed 2 acquisitions, including Rx Med and Uvanta. PharmScript offers products and services including Pharmacy Expertise, Cost Containment, and Technology Solutions. PharmScript operates in a competitive market with competitors including phs, UPMC Health Plan, Beijing Dakang Medical Investment, Norway Health Tech and Deenova, among others.
- Headquarter Somerset, United States
- Employees 376 as on 31 Dec, 2022
- Founders Saul Greenberger
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pharmscript Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
376
as on Dec 31, 2022
-
Investments & Acquisitions
Rx Med
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PharmScript
PharmScript offers a comprehensive portfolio of products and services, including Pharmacy Expertise, Cost Containment, and Technology Solutions.
Provides specialized medication management for care facilities
Helps manage costs in pharmaceutical operations for providers
Offers tools for reliable medication delivery and tracking
People of PharmScript
Unlock access to complete
Funding Insights of PharmScript
Investors in PharmScript
PharmScript has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Summit Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Summit Partners is recognized as a growth equity investment firm.
|
Locked | Locked | Locked |
Investor details for PharmScript
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PharmScript
PharmScript has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Rx Med and Uvanta.
Investment portfolio details for PharmScript
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Standalone pharmacy
|
Locked | Locked | 2007 | Locked | |
|
A chain of pharmacies is operated across the United States.
|
Locked | Locked | 2004 | Locked |
Complete acquisition details for PharmScript
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - PharmScript
Detailed financials for PharmScript
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pharmscript Comparisons
Peer comparison for PharmScript
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PharmScript
PharmScript operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as phs, UPMC Health Plan, Beijing Dakang Medical Investment, Norway Health Tech and Deenova, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Washroom hygiene, floor cleaning, and healthcare services are provided.
|
|
| Locked | Locked | Locked |
Delivers comprehensive healthcare insurance services.
|
|
| Locked | Locked | Locked |
Healthcare management services are provided in the medical sector.
|
|
| Locked | Locked | Locked |
A chain of general hospitals is operated in Norway.
|
|
| Locked | Locked | Locked |
Provider of automation software and medical facilities development services for healthcare
|
Detailed competitors of PharmScript
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharmscript
Complete news archive for PharmScript
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PharmScript
PharmScript was founded in 2009 and raised its 1st funding round 7 years after it was founded.
PharmScript is headquartered in Somerset, United States.
Michael Segal is the current CEO of PharmScript.
As of Dec 31, 2022, the latest employee count at PharmScript is 376.
Founded in 2009 and headquartered in Somerset, United States, PharmScript operates in the pharmacy services sector. Services are delivered to long-term and post-acute care facilities, encompassing medication management, cost containment strategies, and technological support for patient care. Technology is employed to facilitate timely and accurate medication delivery, with operations focused on achieving clinical outcomes while addressing cost management needs.
PharmScript's top competitors include phs, Deenova and Beijing Dakang Medical Investment.
PharmScript offers Pharmacy Expertise, Cost Containment, and Technology Solutions.
PharmScript has 1 investor. Key investors include Summit Partners.